David lagares

Company: Zenon Biotech

Job title: CEO

Seminars:

Examining Target Product Profile: From Signalling Cascades to Cell Types & Immunomodulatory Proteins – What is the Best Target & Most Effective Modality 4:30 pm

Discuss the most promising signalling cascades, cell types, and immunomodulatory proteins that can be targeted to effectively combat fibrosis Analyse different therapeutic modalities, including small molecules, biologics, and gene therapies, to identify the most effective and precise approach to targeting fibrosis with as few side effects as possibleRead more

day: Day One

Shaping the Future of Antifibrotic Therapeutics with Exploration of Expansion Opportunities & Key Considerations 4:00 pm

This session will explore and evaluate emerging trends, identify innovative approaches to differentiate products and strategic insights on how to advance antifibrotic drug development and patient care across a broad spectrum of diseases. Examine the driving factors behind progress and how best to capitalize on these to explore your future expansion strategies.Read more

day: Day One

Forget Fibroblasts? Examining Fibrosis as a Process & the Cell Types Beyond Fibroblasts that Play a Role in Driving Fibrosis 9:05 am

This interactive workshop provides a comprehensive understanding of fibrosis as a multifaceted process, highlighting the role of various cell types beyond fibroblasts including granulocytes, NK cells, neutrophils and beyond. By examining the contributions of different cellular players and their interactions, explore novel therapeutic targets and strategies to address fibrosis across different indications. Delve into: Understanding…Read more

day: Pre-Conference Day